Dyne Therapeutics : DYN

All Dyne Therapeutics Articles

66 Articles

Douglas A. McIntyre | Jun 25, 2009 at 6:37 AM EDT

Top Analyst Upgrades and Downgrades (GLW, CPN, DYN, DE, EIX, IR, LM, STX, SLM, WOOF)

These are this Thursday’s top ten independent analyst calls with upgrades, downgrades and initiations from Wall Street brokerage firms with…

Douglas A. McIntyre | Apr 20, 2009 at 7:13 AM EDT

Top 10 Analyst Upgrades/Downgrades (AMZN, BEBE, DYN, ENR, JNPR, JNJ, LVS, NFLX, PG, SKS)

These are the top ten analyst upgrades and downgrades we have seen from Wall Street this Monday morning: Amazon.com (AMZN)…

Douglas A. McIntyre | Dec 2, 2008 at 8:18 AM EST

Electricity Use Falling–So Are Share Prices (DUK, DYN, AEP)

Just as with natural gas and crude oil, electricity use is off as the economy heads into its second year…

Douglas A. McIntyre | Feb 13, 2008 at 7:34 AM EST

Top 10 Pre-Market Analyst Calls (CPLA, CEPH, DYN, HBC, MS, SGP, SLM, TASR, TROW, VISN)

Below are the top analyst calls that a673b.bigscoots-temp.com is looking at this morning: Capella Education (NASDAQ: CPLA) started as Neutral…

Douglas A. McIntyre | May 10, 2007 at 5:52 PM EDT

Cramer’s Sell Block (May 10, 2007)

On tonight’s Sell Block on CNBC’s MAD MONEY, Jim Cramer reviewed many of his picks you need to sell: He…

Douglas A. McIntyre | May 8, 2007 at 6:54 AM EDT

Dynegy Reports; Is It Good Enough?

Dynegy Inc. (DYN-NYSE) reported EPS of $0.03 on stronger-than-expected weather-driven demand and higher power prices; up from -$0.01 last year…

1 … 3 4 5

Dyne Therapeutics : DYN

All Dyne Therapeutics Articles

Top Analyst Upgrades and Downgrades (GLW, CPN, DYN, DE, EIX, IR, LM, STX, SLM, WOOF)

Top 10 Analyst Upgrades/Downgrades (AMZN, BEBE, DYN, ENR, JNPR, JNJ, LVS, NFLX, PG, SKS)

Electricity Use Falling–So Are Share Prices (DUK, DYN, AEP)

Top 10 Pre-Market Analyst Calls (CPLA, CEPH, DYN, HBC, MS, SGP, SLM, TASR, TROW, VISN)

Cramer’s Sell Block (May 10, 2007)

Dynegy Reports; Is It Good Enough?

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Dyne Therapeutics : DYN

All Dyne Therapeutics Articles

Top Analyst Upgrades and Downgrades (GLW, CPN, DYN, DE, EIX, IR, LM, STX, SLM, WOOF)

Top 10 Analyst Upgrades/Downgrades (AMZN, BEBE, DYN, ENR, JNPR, JNJ, LVS, NFLX, PG, SKS)

Electricity Use Falling–So Are Share Prices (DUK, DYN, AEP)

Top 10 Pre-Market Analyst Calls (CPLA, CEPH, DYN, HBC, MS, SGP, SLM, TASR, TROW, VISN)

Cramer’s Sell Block (May 10, 2007)

Dynegy Reports; Is It Good Enough?

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s